Target intelligence / Profile preview

Brain microvascular endothelial cell plasma membrane (BMEC plasma membrane)

Target
BMEC plasma membrane
Molecular classification
Other
01

Overview

The brain microvascular endothelial cell (BMEC) plasma membrane is the primary physical and metabolic component of the blood-brain barrier (BBB), which maintains the homeostatic environment of the central nervous system [PMID: 30013157]. It is distinguished by the presence of continuous tight junctions that restrict the paracellular movement of ions and polar molecules [PMID: 26431203]. This membrane expresses a variety of specific transport systems, including carrier-mediated transporters like GLUT1 for glucose and receptor-mediated transcytosis systems for larger molecules like transferrin [PMID: 29460252]. Additionally, it contains potent efflux transporters such as P-glycoprotein that actively remove xenobiotics from the brain [PMID: 28107447]. Dysfunction of the BMEC plasma membrane is a hallmark of several neurological conditions, including stroke, where barrier breakdown leads to vasogenic edema, and Alzheimer's disease, where transport mechanisms are impaired [PMID: 32051548]. For drug developers, this membrane represents the most significant hurdle for CNS-targeted therapies, requiring specialized delivery strategies to bypass its restrictive properties [PMID: 23839168].

Other names
Blood-brain barrier endothelial membraneBrain capillary endothelial cell membraneBMEC membraneBBB endothelial plasma membrane
02

Mechanism of action

Osmotic disruption of tight junctions, carrier-mediated transport, receptor-mediated transcytosis, and inhibition of efflux transporters.

03

Biological functions

Blood-brain barrier maintenanceSelective permeabilityTranscellular transportEfflux of xenobioticsCell-cell adhesion
04

Disease associations

Neurodegenerative diseaseStrokeMultiple sclerosisBrain tumorNeuroinflammation
05

Safety considerations

Neurotoxicity from barrier disruptionCerebral edemaOff-target CNS effectsImpaired nutrient delivery
06

Interacting drugs

Mannitol

4 more in the full profile.

07

Biomarkers

Claudin-5OccludinZonula occludens-1 (ZO-1)Glucose transporter 1 (GLUT1/SLC2A1)P-glycoprotein (ABCB1)

Beyond the preview

Go deeper on Brain microvascular endothelial cell plasma membrane (BMEC plasma membrane).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain microvascular endothelial cell plasma membrane (BMEC plasma membrane).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call